Mayuko Amaha

536 total citations
8 papers, 76 citations indexed

About

Mayuko Amaha is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Mayuko Amaha has authored 8 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Surgery. Recurrent topics in Mayuko Amaha's work include Chronic Kidney Disease and Diabetes (4 papers), Diabetes Treatment and Management (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Mayuko Amaha is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Diabetes Treatment and Management (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Mayuko Amaha collaborates with scholars based in Japan. Mayuko Amaha's co-authors include Tsukasa Nakamura, Eiichi Sato, Mayumi Nomura, Daisuke Matsumura, Yoshihiko Ueda, Sayaka Maeda, Yasuhiro Kawagoe, Sho‐ichi Yamagishi, Hidetsugu Yamagishi and Jun‐ichi Oyama and has published in prestigious journals such as Journal of Hypertension, Diabetes Research and Clinical Practice and Toxins.

In The Last Decade

Mayuko Amaha

7 papers receiving 76 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayuko Amaha Japan 6 38 25 22 20 12 8 76
Cyrielle Tréard France 6 20 0.5× 49 2.0× 15 0.7× 11 0.6× 10 0.8× 8 82
Doreen Zhu United Kingdom 5 24 0.6× 13 0.5× 20 0.9× 37 1.9× 18 1.5× 9 80
No Authors 4 41 1.1× 13 0.5× 21 1.0× 19 0.9× 28 2.3× 18 94
Daniel Barraca Spain 6 98 2.6× 24 1.0× 17 0.8× 18 0.9× 20 1.7× 9 139
M Baldassarre Italy 5 15 0.4× 14 0.6× 39 1.8× 26 1.3× 14 1.2× 9 95
Katherine M. Dell United States 4 60 1.6× 11 0.4× 14 0.6× 7 0.3× 7 0.6× 8 94
Shuxia Fu China 3 24 0.6× 13 0.5× 7 0.3× 13 0.7× 5 0.4× 7 61
Aaltje Y Adema Netherlands 6 85 2.2× 17 0.7× 14 0.6× 5 0.3× 8 0.7× 9 111
Jan AJG van den Brand Netherlands 3 49 1.3× 5 0.2× 18 0.8× 11 0.6× 5 0.4× 3 74
И Е Чазова Russia 5 26 0.7× 8 0.3× 8 0.4× 37 1.9× 8 0.7× 27 71

Countries citing papers authored by Mayuko Amaha

Since Specialization
Citations

This map shows the geographic impact of Mayuko Amaha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayuko Amaha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayuko Amaha more than expected).

Fields of papers citing papers by Mayuko Amaha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayuko Amaha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayuko Amaha. The network helps show where Mayuko Amaha may publish in the future.

Co-authorship network of co-authors of Mayuko Amaha

This figure shows the co-authorship network connecting the top 25 collaborators of Mayuko Amaha. A scholar is included among the top collaborators of Mayuko Amaha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayuko Amaha. Mayuko Amaha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Tanaka, Hiroaki, Takao Ono, Hongmei Lü, et al.. (2023). PS-R05-8: THREE PATIENTS WITH CHRONIC KIDNEY DISEASE WHEREIN ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR WAS EFFECTIVE AGAINST HEART FAILURE AND HIGH BLOOD PRESSURE. Journal of Hypertension. 41(Suppl 1). e445–e445.
2.
Ono, Takao, Hongmei Lü, Daisuke Matsumura, et al.. (2022). Effects of Zinc Acetate Hydrate Supplementation on Renal Anemia with Hypozincemia in Hemodialysis Patients. Toxins. 14(11). 746–746. 7 indexed citations
3.
Sato, Eiichi, Atsushi Tanaka, Jun‐ichi Oyama, et al.. (2015). Long-term effects of AST-120 on the progression and prognosis of pre-dialysis chronic kidney disease: a 5-year retrospective study. Heart and Vessels. 31(10). 1625–1632. 20 indexed citations
4.
Sato, Eiichi, Mayuko Amaha, Mayumi Nomura, et al.. (2014). LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: A retrospective analysis. Diabetes Research and Clinical Practice. 106(2). 241–246. 6 indexed citations
5.
Sato, Eiichi, Tsukasa Nakamura, Mayuko Amaha, et al.. (2014). Effect of Tolvaptan in Patients With Chronic Kidney Disease Due to Diabetic Nephropathy With Heart Failure. International Heart Journal. 55(6). 533–538. 17 indexed citations
6.
Nakamura, Tsukasa, Eriko Sato, Mayuko Amaha, et al.. (2012). Ezetimibe Reduces Urinary Albumin Excretion in Hypercholesterolaemic Type 2 Diabetes Patients with Microalbuminuria. Journal of International Medical Research. 40(2). 798–803. 8 indexed citations
7.
Nakamura, Tsukasa, Eiichi Sato, Mayuko Amaha, et al.. (2011). Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria. Journal of the Renin-Angiotensin-Aldosterone System. 13(1). 122–127. 14 indexed citations
8.
Amaha, Mayuko, Yasushi Ohashi, Ken Sakai, Atsushi Aikawa, & Sonoo Mizuiri. (2010). [Salt intake and the progression of renal failure in patients with chronic kidney disease].. PubMed. 52(7). 952–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026